日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Noncanonical functions of UGT2B17 promote castration-resistant prostate cancer progression.

UGT2B17 的非经典功能促进去势抵抗性前列腺癌的进展。

Feng Tingting, Xie Ning, Gao Lin, Jia Qiongqiong, Kung Sonia Hy, Morova Tunc, Li Yinan, Wang Lin, Fazli Ladan, Lacombe Louis, Guillemette Chantal, Lévesque Eric, Lack Nathan A, Qi Jianfei, Han Bo, Dong Xuesen

Elucidating molecularly stratified single agent, and combination, therapeutic strategies targeting MCL1 for lethal prostate cancer.

阐明针对致命性前列腺癌的 MCL1 分子分层单药和联合治疗策略。

Jiménez-Vacas Juan M, Westaby Daniel, Figueiredo Ines, De Haven Brandon Alexis, Padilha Ana, Yuan Wei, Seed George, Bogdan Denisa, Gurel Bora, Bertan Claudia, Miranda Susana, Lambros Maryou, Montero-Hidalgo Antonio J, Coleman Ilsa, Yu Ivan Pak Lok, Buroni Lorenzo, Zeng Wanting, Neeb Antje J, Welti Jon, Rekowski Jan, Paravati Roberta, Gabel Florian, Pandell Nicole, Ferreira Ana, Crespo Mateus, Riisnaes Ruth, Das Souvik, Taylor Joe, Waldron Nick, Hobern Emily, Valenti Melanie, Ning Jian, Bernett Ilona, Liodaki Kate, Persse Thomas, Galipeau Patricia, Wilkinson Scott, Trostel Shana Y, Karzai Fatima, Chau Cindy H, Beatson Erica L, Zhang Xiaohu, Klumpp-Thomas Carleen, Varkaris Andreas, Luque Raul M, Swain Amanda, Raynaud Florence, Lack Nathan A, Thomas Craig J, Ha Gavin, Figg William D, Bezzi Marco, Sowalsky Adam G, Nelson Peter S, Carreira Suzanne, Balk Steven P, de Bono Johann S, Sharp Adam

Chromatin-focused genetic and chemical screens identify BRPF1 as a targetable vulnerability in Taxol-resistant triple-negative breast cancer.

以染色质为中心的遗传和化学筛选发现 BRPF1 是紫杉醇耐药三阴性乳腺癌的一个可靶向的脆弱点

Yedier-Bayram Ozlem, Cingöz Ahmet, Yilmaz Ebru, Aksu Ali Cenk, Esin Beril, Degirmenci Nareg, Cavga Ayse Derya, Dedeoğlu Beyza, Cevatemre Buse, Syed Hamzah, Philpott Martin, Cribbs Adam P, Oppermann Udo, Lack Nathan A, Acilan Ceyda, Onder Tamer T, Bagci-Onder Tugba

Comprehensive functional annotation of ESR1-driven enhancers in breast cancer reveals hierarchical activity independent of genomic and epigenomic contexts

对乳腺癌中 ESR1 驱动的增强子进行全面的功能注释,揭示了独立于基因组和表观基因组背景的层级活性

Zekri, Yanis; Gregoricchio, Sebastian; Yapıcı, Elif; Huang, Chia-Chi Flora; Morova, Tunç; Altıntaş, Umut Berkay; Korkmaz, Gozde; Lack, Nathan A; Zwart, Wilbert

Coregulators determine androgen receptor activity in prostate cancer

辅助调节因子决定前列腺癌中雄激素受体的活性

Yavuz, Kerim; Lack, Nathan A

Curcuphenol possesses an unusual histone deacetylase enhancing activity that counters immune escape in metastatic tumours

姜黄酚具有一种不寻常的组蛋白去乙酰化酶增强活性,可对抗转移性肿瘤的免疫逃逸。

Ellis, Samantha L S; Dada, Sarah; Nohara, Lilian L; Saranchova, Iryna; Munro, Lonna; Pfeifer, Cheryl G; Eyford, Brett A; Morova, Tunc; Williams, David E; Cheng, Ping; Lack, Nathan A; Andersen, Raymond J; Jefferies, Wilfred A

EPIKOL, a chromatin-focused CRISPR/Cas9-based screening platform, to identify cancer-specific epigenetic vulnerabilities

EPIKOL 是一个基于 CRISPR/Cas9 的染色质靶向筛选平台,用于识别癌症特异性的表观遗传脆弱性。

Yedier-Bayram, Ozlem; Gokbayrak, Bengul; Kayabolen, Alisan; Aksu, Ali Cenk; Cavga, Ayse Derya; Cingöz, Ahmet; Kala, Ezgi Yagmur; Karabiyik, Goktug; Günsay, Rauf; Esin, Beril; Morova, Tunc; Uyulur, Fırat; Syed, Hamzah; Philpott, Martin; Cribbs, Adam P; Kung, Sonia H Y; Lack, Nathan A; Onder, Tamer T; Bagci-Onder, Tugba

Deletion of conserved protein phosphatases reverses defects associated with mitochondrial DNA damage in Saccharomyces cerevisiae

酿酒酵母中保守蛋白磷酸酶的缺失可逆转与线粒体DNA损伤相关的缺陷

Garipler, Görkem; Mutlu, Nebibe; Lack, Nathan A; Dunn, Cory D

Genetic variants of MARCO are associated with susceptibility to pulmonary tuberculosis in a Gambian population

MARCO基因的遗传变异与冈比亚人群中肺结核的易感性相关

Bowdish, Dawn Me; Sakamoto, Kaori; Lack, Nathan A; Hill, Philip C; Sirugo, Giorgio; Newport, Melanie J; Gordon, Siamon; Hill, Adrian Vs; Vannberg, Fredrick O

New therapeutics to treat castrate-resistant prostate cancer

治疗去势抵抗性前列腺癌的新疗法

Acar, Omer; Esen, Tarık; Lack, Nathan A